Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Common Equity (2018 - 2025)

Viemed Healthcare's Common Equity history spans 8 years, with the latest figure at $141.5 million for Q4 2025.

  • For Q4 2025, Common Equity rose 6.18% year-over-year to $141.5 million; the TTM value through Dec 2025 reached $141.5 million, up 6.18%, while the annual FY2025 figure was $141.5 million, 6.18% up from the prior year.
  • Common Equity reached $141.5 million in Q4 2025 per VMD's latest filing, up from $133.6 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $141.6 million in Q2 2025 to a low of $83.4 million in Q1 2021.
  • Average Common Equity over 5 years is $110.6 million, with a median of $106.7 million recorded in 2023.
  • Peak YoY movement for Common Equity: surged 70.96% in 2021, then rose 2.4% in 2022.
  • A 5-year view of Common Equity shows it stood at $94.8 million in 2021, then rose by 2.4% to $97.1 million in 2022, then increased by 17.3% to $113.9 million in 2023, then increased by 17.04% to $133.3 million in 2024, then increased by 6.18% to $141.5 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Common Equity are $141.5 million (Q4 2025), $133.6 million (Q3 2025), and $141.6 million (Q2 2025).